Table 3.
Outcome measures: patient outcomes
| Intermediate outcome indicators | Baseline | Short term (one year follow up) |
Long term (two years follow up) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Medical record (n = 1,861) |
Intervention | (SD) | Control | (SD) | Intervention | (SD) | Control | (SD) | Intervention | (SD) | Control | (SD) |
| Mean HbA1C mmol/l (SD) | 7.5 | (1.3) | 7.5 | (1.2) | 7.3 | (1.2) | 7.4 | (1.2) | 7.2 | (1.2) | 7.2 | (1.2) |
| Mean systolic blood pressure mm Hg (SD) |
143.3 | (19.2) | 143.4 | (17.2) | 141.6 | (18.1) | 141.6 | (16.5) | 139.3 | (17.4) | 141.8* | (16.5) |
| Mean diastolic blood pressure mm Hg (SD) |
80.4 | (8.8) | 80.2 | (8.9) | 79.3 | (8.8) | 78.9 | (8.6) | 78.5 | (9.1) | 78.7 | (8.6) |
| Mean cholesterol | 4.9 | (0.9) | 4.9 | (1.1) | 4.6 | (0.9) | 4.6 | (0.9) | 4.4 | (0.9) | 4.5 | (0.9) |
| Mean HDL | 1.3 | (0.4) | 1.3 | (0.4) | 1.3 | (0.4) | 1.3 | (0.4) | 1.4 | (0.4) | 1.3** | (0.4) |
| Mean LDL | 2.8 | (0.9) | 2.9 | (0.9) | 2.7 | (0.9) | 2.6 | (2.0) | 2.5 | (0.8) | 2.6 | (2.0) |
| Mean BMI | 29.7 | (5.6) | 29.6 | (4.9) | 29.7 | (5.3) | 29.5 | (4.9) | 29.9 | (5.5) | 29.7 | (4.9) |
| Mean triglycerides | 1.9 | (1.1) | 1.9 | (1.3) | 1.8 | (1.1) | 1.8 | (1.1) | 1.7 | (1.1) | 1.8 | (1.1) |
| Nonsmokers (in percentages) | 83.5 | 83.3 | 84.5 | 84.9 | 83.7 | 85.7 | ||||||
*p < 0.05; **p < 0.001
BMI, Body mass index; HDL = high density lipoprotein; LDL = low density lipoprotein
Patient outcome scores are presented as unadjusted.
P value is for testing the difference between intervention and control arm at baseline and one year follow up respectively baseline and two yearsfollow up using a mixed logistic model for dichotomous outcomes, and a mixed regression model for continuous outcomes adjusting for baseline scores.